Analysis of the reasons behind the high domestic selling price of Wansaiwei

The reason why the selling price of Valcyte () in the domestic market remains high is due to multiple factors at play, which mainly involve the research and development investment of the original drug, the complexity of the production process, the cost of the import link, and the market supply and demand pattern. Here's a closer look at these key factors:

1.The high cost of research and development of original drugs: Vancevir is an original drug developed by Roche Pharmaceuticals. The entire process from laboratory research and development to clinical trials and finally to the market is time-consuming and involves huge financial investment. It usually takes more than ten years and hundreds of millions or even billions of capital investment. These costs will eventually be reflected in the pricing of drugs and become the root cause of the high prices of original drugs.

2.The complexity of the production process: The production process of Valganciclovir (Valganciclovir), the active ingredient of Valgancivir, is complex and requires extremely high equipment and quality control. At the same time, in order to meet international certification standards, a large amount of resources need to be invested in the production process, which increases the production cost of pharmaceuticals.

3.Import duties and transportation fees: As an imported drug, Vancevi needs to pay duties and transportation fees when entering the domestic market. In addition, strict registration and approval by the National Medical Products Administration are required. These steps increase the cost of drugs, thereby pushing up the selling price.

4.Not included in the medical insurance catalog: At present, Vancevir has not been included in China's medical insurance catalog, and patients need to purchase it in full at their own expense. This makes the price of drugs more burdensome for patients, and the problem of high selling prices becomes more prominent.

5.Insufficient competition in the generic drug market: In the domestic market, Vancevi has not yet faced extensive competition from generic drugs, and the original drug therefore occupies a dominant position in the market. In the absence of price competition, it is naturally difficult to reduce the price of imported original drugs.

For patients with greater financial pressure, they can consider choosing lower-priced versions of overseas original drugs, such as the Turkish version or the Indian version. The ingredients and efficacy of these versions are the same as the domestic version, but the price is only about three to four thousand yuan. At the same time, you can also pay attention to updates on charitable assistance projects or the National Medical Insurance Directory to obtain more medication options and financial support.

xa0

Reference materials

《ValcyteOfficial website drug information》 https://www.drugs.com/pro/valganciclovir.html